Biomarkers of Oxidative Stress for Neonatal Lung Disease

The transition from prenatal to postnatal life causes a significant increase in arterial oxygen tension and the activation of metabolic pathways enabling the newborn's adaptation to the extra-uterine environment. The balance between pro-oxidant and anti-oxidant systems is critical to preserve cellular functions. Indeed, oxidative stress (OS) occurs when the production of free radicals is not balanced by the activity of intracellular antioxidant systems, contributing to cellular and tissue damage. Perinatal OS may have serious health consequences during the postnatal period and later in life. Namely, OS has been recognized as the major cause of lung injury in newborns, especially those preterm born, due to their immature lung and antioxidant systems. The development of OS biomarkers has gained increasing research interest since they may provide useful insights about pathophysiological pathways underlying OS-mediated pulmonary diseases in newborns. Moreover, their implementation in clinical settings may help to early identify high risk-newborns and to provide targeted treatment. Ideally, a biomarker should demonstrate ease of use, biological validity and reproducibility, high sensitivity and specificity. However, none of the clinically validated biomarkers so far have been qualified for neonatal lung disease. Additionally, the complex technical procedures and the high cost of such determinations have hampered the use of OS biomarkers in clinical practice. This review aims to evaluate the current evidence on the application of biomarkers of oxidative stress for neonatal lung disease and exploring the most relevant issues affecting their implementation in practice, as well as the associated evidence gaps and research limitations.

[1]  G. Buonocore,et al.  Oxidative stress biomarkers in the perinatal period: Diagnostic and prognostic value. , 2020, Seminars in fetal & neonatal medicine.

[2]  G. Buonocore,et al.  Biomarkers of oxidative stress in the fetus and in the newborn. , 2019, Free radical biology & medicine.

[3]  J. Galano,et al.  Non-invasive assessment of oxidative stress in preterm infants. , 2019, Free radical biology & medicine.

[4]  R. Granese,et al.  Role of oxidative stress in neonatal respiratory distress syndrome. , 2019, Free radical biology & medicine.

[5]  L. Sherif,et al.  Oxidative Stress and Anti-Oxidant Markers in Premature Infants with Respiratory Distress Syndrome , 2019, Open access Macedonian journal of medical sciences.

[6]  A. Nada,et al.  Oxidative stress markers in neonatal respiratory distress syndrome: advanced oxidation protein products and 8-hydroxy-2-deoxyguanosine in relation to disease severity , 2019, Pediatric Research.

[7]  A. Parra-Llorca,et al.  Oxidative Stress in the Newborn Period: Useful Biomarkers in the Clinical Setting , 2018, Antioxidants.

[8]  Shixia Huang,et al.  Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[9]  G. Buonocore,et al.  The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside , 2018, Oxidative medicine and cellular longevity.

[10]  A. Ahmed,et al.  Circulating Protein Carbonyls, Antioxidant Enzymes and Related Trace Minerals among Preterms with Respiratory Distress Syndrome. , 2017, Journal of clinical and diagnostic research : JCDR.

[11]  S. London,et al.  Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis , 2017, Redox biology.

[12]  A. Parra-Llorca,et al.  Oxygen and oxidative stress in the perinatal period , 2017, Redox biology.

[13]  Rei-Cheng Yang,et al.  Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia. , 2017, Pediatrics and neonatology.

[14]  Yi-Chia Huang,et al.  Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection , 2017, PloS one.

[15]  Yulong Yin,et al.  Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? , 2016, Oxidative medicine and cellular longevity.

[16]  L. Deterding,et al.  Reinterpreting the best biomarker of oxidative stress: The 8-iso-prostaglandin F2α/prostaglandin F2α ratio shows complex origins of lipid peroxidation biomarkers in animal models. , 2016, Free radical biology & medicine.

[17]  G. Buonocore,et al.  Fetal programming and early identification of newborns at high risk of free radical-mediated diseases. , 2016, World journal of clinical pediatrics.

[18]  A. Fabiano,et al.  The development of lung biochemical monitoring can play a key role in the early prediction of bronchopulmonary dysplasia , 2016, Acta paediatrica.

[19]  Jamie M. Verheyden,et al.  A three-dimensional study of alveologenesis in mouse lung. , 2016, Developmental biology.

[20]  Y. Ohshima,et al.  Carboxyhemoglobin Formation in Preterm Infants Is Related to the Subsequent Development of Bronchopulmonary Dysplasia , 2015, Disease markers.

[21]  J. Kuligowski,et al.  Urinary Lipid Peroxidation Byproducts: Are They Relevant for Predicting Neonatal Morbidity in Preterm Infants? , 2015, Antioxidants & redox signaling.

[22]  T. Grune,et al.  Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: Focus on sample preparation and derivatization conditions , 2015, Redox biology.

[23]  A. Marino Gammazza,et al.  Oxidative stress markers at birth: Analyses of a neonatal population. , 2015, Acta histochemica.

[24]  F. Bany-Mohammed,et al.  Antioxidants and Biomarkers of Oxidative Stress in Preterm Infants with Symptomatic Patent Ductus Arteriosus , 2015, American Journal of Perinatology.

[25]  K. Karki,et al.  A novel approach to study oxidative stress in neonatal respiratory distress syndrome , 2014, BBA clinical.

[26]  S. Berkelhamer,et al.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease. , 2014, Antioxidants & redox signaling.

[27]  G. Konduri,et al.  OPTICAL IMAGING OF LIPOPOLYSACCHARIDE-INDUCED OXIDATIVE STRESS IN ACUTE LUNG INJURY FROM HYPEROXIA AND SEPSIS , 2013, Journal of innovative optical health sciences.

[28]  Changlian Zhu,et al.  Characteristics of Respiratory Distress Syndrome in Infants of Different Gestational Ages , 2013, Lung.

[29]  G. Buonocore,et al.  Biomarkers of oxidative stress in fetal and neonatal diseases , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[30]  J. Aschner,et al.  Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus , 2012, Pediatric Research.

[31]  G. Buonocore,et al.  Oxidative Stress and Bronchopulmonary Dysplasia , 2012, Journal of clinical neonatology.

[32]  R. Omdal,et al.  Improved detection of advanced oxidation protein products in plasma. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[33]  Chang Won Choi,et al.  Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia , 2011, Free radical research.

[34]  J. Gien,et al.  Pathogenesis and treatment of bronchopulmonary dysplasia , 2011, Current opinion in pediatrics.

[35]  G. Buonocore,et al.  Early identification of the risk for free radical-related diseases in preterm newborns. , 2010, Early human development.

[36]  F. Perez-Vizcaino,et al.  Isoprostanes in fetal and neonatal health and disease. , 2010, Free radical biology & medicine.

[37]  J. Sastre,et al.  Preterm Resuscitation With Low Oxygen Causes Less Oxidative Stress, Inflammation, and Chronic Lung Disease , 2009, Pediatrics.

[38]  Xin Meng,et al.  Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells , 2009, BMC Cancer.

[39]  M. Stampanoni,et al.  Developmental alveolarization of the mouse lung , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[40]  E. Baraldi,et al.  Chronic lung disease after premature birth. , 2007, The New England journal of medicine.

[41]  F. Groenendaal,et al.  Anti-oxidant strategies. , 2007, Seminars in fetal & neonatal medicine.

[42]  T. Silberstein,et al.  Oxidative stress as determined by glutathione (GSH) concentrations in venous cord blood in elective cesarean delivery versus uncomplicated vaginal delivery , 2007, Archives of Gynecology and Obstetrics.

[43]  G. Buonocore,et al.  Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. , 2004, Free radical biology & medicine.

[44]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[45]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[46]  G. Buonocore,et al.  Oxidative Stress in Preterm Neonates at Birth and on the Seventh Day of Life , 2002, Pediatric Research.

[47]  Leona W Ayers,et al.  Surveillance of ventilator-associated pneumonia in very-low-birth-weight infants. , 2002, American journal of infection control.

[48]  L. Wood,et al.  Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors , 2001, Journal of the American College of Nutrition.

[49]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[50]  A. Jobe.  The New BPD: An Arrest of Lung Development , 1999, Pediatric Research.

[51]  O. Saugstad.  Chronic Lung Disease: The Role of Oxidative Stress , 1998, Neonatology.

[52]  M. Anderson,et al.  Glutathione: an overview of biosynthesis and modulation. , 1998, Chemico-biological interactions.

[53]  D. T. Harwood,et al.  Biomarkers of Neutrophil-Mediated Glutathione and Protein Oxidation in Tracheal Aspirates From Preterm Infants: Association With Bacterial Infection , 2011, Pediatric Research.

[54]  A. MartorellAragonés,et al.  Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma. , 2010 .

[55]  J. Morrow,et al.  Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. , 2007, Methods in enzymology.

[56]  V. Bhandari,et al.  Hyperoxia Causes an Increase in Antioxidant Enzyme Activity in Adult and Fetal Rat Type II Pneumocytes , 2000, Lung.